EUPRAXIA PHARMACEUTICALS INC. Cash
EUPRAXIA PHARMACEUTICALS INC. (EPRX) had Cash of $80.56 million as of 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-03-13
- 2025-12-31: Cash $80.56M.
- 2024-12-31: Cash $33.10M.
- 2023-12-31: Cash $19.34M.
- 2022-12-31: Cash $10.83M.
| Period end | Cash |
|---|---|
| 2025-12-31 | $80.56M 40-F · filed 2026-03-13 |
| 2024-12-31 | $33.10M 40-F · filed 2026-03-13 |
| 2023-12-31 | $19.34M 40-F · filed 2025-03-20 |
| 2022-12-31 | $10.83M 40-F · filed 2024-04-01 |